Finance

Lists
Why is ADRX down 4.76%?
Dive Deeper
ADRX:NASDAQ
ADARx Pharmaceuticals, Inc.
$14.20
-4.76%
(-0.71) 1D
$13.99
-1.48% (-0.21)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADRX...
Open
$14.96
High
$16.17
Low
$13.70
Mkt. cap
1.52B
Avg. vol.
477.86K
Volume
587.96K
52-wk high
$23.21
52-wk low
$12.50
EPS
-$0.82
No. of employees
100
Open
$14.96
High
$16.17
Low
$13.70
Mkt. cap
1.52B
Avg. vol.
477.86K
Volume
587.96K
52-wk high
$23.21
52-wk low
$12.50
EPS
-$0.82
No. of employees
100
News stories
From web sources and news partners
About ADARx Pharmaceuticals, Inc.
CEO-
Employees100
Founded2019
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteadarx.com
Analyst ratings
Based on 4 analysts giving stock ratings to ADRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ADRX in the last 3 months.
Highest
Current $14.20
$38.00 (+167.61%)
Average
$35.00 (+146.48%)
Lowest
$32.00 (+125.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tessa Romero
J.P. Morgan
Buy
Initiated
$38.00
+167.6%
10/20/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
10/20/2026
Michael Ulz
Morgan Stanley
Buy
Initiated
$32.00
+125.4%
10/20/2026
Michael Yee
UBS
Buy
Initiated
$35.00
+146.5%
10/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.62M
1.62M
2.14M
746.00K
Cost of goods sold
20.77M
20.77M
23.58M
24.74M
Cost of revenue
20.77M
20.77M
23.58M
24.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.52M
5.52M
5.62M
5.90M
Operating expense
5.52M
5.52M
5.62M
5.90M
Total operating expenses
26.30M
26.30M
29.20M
30.64M
Operating income
-24.68M
-24.68M
-27.06M
-29.89M
Other non operating income
505.50K
505.50K
411.00K
355.00K
EBT including unusual items
-19.72M
-19.72M
-22.67M
-25.76M
EBT excluding unusual items
-19.72M
-19.72M
-22.67M
-25.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.72M
-19.72M
-22.67M
-25.76M
Net profit margin
-1,217.03%
-1,217.03%
-1,059.21%
-3,452.95%
Earnings per share
-
-
-
-
Interest and investment income
4.45M
4.45M
3.98M
3.78M
Interest expense
-
-
-
-
Net interest expenses
4.45M
4.45M
3.98M
3.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.39M
-24.39M
-26.76M
-29.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps